Monday, June 15, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 946 of 1,261
  1. US 8053448

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted
  2. US 8053412

    NELL-1 peptides

    The Regents of the University of California · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted
  3. US 8052970

    Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted
  4. US 8053416

    Isolation and structure of turbostatins 1-4

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted
  5. US 8053422

    Anti-cancer oligodeoxynucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted
  6. US 8053487

    Multifunctional acrylates used as cross-linkers in dental and biomedical self-etching bonding adhesives

    United States of America as represented by the Secretary of the Air Force · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted
  7. US 8048222

    Highly pure modafinil

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  8. US 8049016

    Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymes

    Xenon Pharmaceuticals Inc. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  9. US 8048902

    Antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  10. US 8049015

    Heteroaryl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  11. US 8048418

    Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  12. US 8048906

    Optically pure and enriched isomers of chelating ligands and contrast agents

    Catalyst Medical · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  13. US 8048990

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  14. US 8048909

    Proton pump inhibitors

    Takeda Pharmaceutical Company Limited · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  15. US 8048889

    3,4-disubstituted coumarin and quinolone compounds

    XTL BIOPHARMACEUTICALS LTD. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  16. US 8048851

    Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response

    The Regents of the University of California · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  17. US 8048415

    Compositions and methods for promoting or inhibiting angiogenesis

    Northwestern University · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  18. US 8048427

    Subgenomic replicons of the flavivirus dengue

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  19. US 8048646

    NELL peptide expression systems and bone formation activity of NELL peptide

    The Regents of the University of California · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  20. US 8048432

    Polysaccharide-protein conjugate vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  21. US 8048844

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  22. US 8044187

    Human luteinizing hormone superagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted
  23. US 8044093

    Pharmaceutical compositions comprising docetaxel and methods for preparation thereof

    Beijing Century Biocom Pharmaceutical Technology Co., Ltd. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted
  24. US 8044049

    Fused heterocyclic derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.